{"filing":{"accession_number":"0001493152-26-034430","cik":"0001433607","ticker":"NSPR","company_name":"InspireMD, Inc.","form":"8-K","filing_date":"2026-07-23","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226034430/form8-k.htm"},"events":[{"id":20169,"run_id":18157,"accession_number":"0001493152-26-034430","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"InspireMD received a notice from Nasdaq on July 17, 2026 that it failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has been given a 180-day compliance period until January 13, 2027 to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":19467,"accession_number":"0001493152-26-034430","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"InspireMD received a notice from Nasdaq on July 17, 2026 that it failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has been given a 180-day compliance period until January 13, 2027 to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T21:01:36.113140+00:00","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-07-23"}]}